← Leaderboards
Jeffrey M. Brown
Sensorium Therapeutics Inc
$2,019,940
Attributed
$2,019,940
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,019,940 · 1
By mechanism
R44$2,019,940 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAdverse Event RiskAmyloidAlkaloidsAnti-Depressive AgentsAlzheimerâS Disease BiomarkerAcetylcholinesterase InhibitorsAbcb1 GeneAnimal ModelAntibody TherapyBotanicalsAnxietyAnxiety DisordersApp-Ps1BrainAssociated SymptomAutomobile DrivingAlgorithmsBiological AvailabilityBloodBlood-Brain Barrier PenetrationBlood-Brain Barrier PermeabilizationCell ModelCellular Assay
Grant awards (2)
A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment$1,517,441
R44 · FY2025 · AG · contact PI
A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment$502,499
R44 · FY2024 · AG · contact PI